Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6594)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2020 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takaya H, Namisaki T, Moriya K, Shimozato N, Kaji K, Ogawa H, Ishida K, Tsuji Y, Kaya D, Takagi H, Fujinaga Y, Nishimura N, Sawada Y, Kawaratani H, Akahane T, Matsumoto M, Yoshiji H. Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma. World J Gastroenterol 2020; 26(45): 7232-7241 [PMID: 33362379 DOI: 10.3748/wjg.v26.i45.7232] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i45/7232.htm |
| Number | Citing Articles |
| 1 |
Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami, Yasuhito Tanaka. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21472-1
|
| 2 |
Hiroaki Takaya, Tadashi Namisaki, Shohei Asada, Satoshi Iwai, Takahiro Kubo, Junya Suzuki, Masahide Enomoto, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, Yasuhiko Sawada, Kosuke Kaji, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Masanori Matsumoto, Hitoshi Yoshiji. ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine 2022; 11(7): 1835 doi: 10.3390/jcm11071835
|
| 3 |
Qi-Feng Wang, Zong-Wei Li, Hai-Feng Zhou, Kun-Zhong Zhu, Ya-Jing Wang, Ya-Qin Wang, Yue-Wei Zhang. Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(6): 2380-2393 doi: 10.4251/wjgo.v16.i6.2380
Abstract(175) |
Core Tip(185) |
Full Article(HTML)(794)
|
Full Article with Cover (PDF)-7036K(42)
|
Audio-779K(3)
|
Peer-Review Report-231K(19)
|
Answering Reviewers-467K(19)
|
Supplementary Material-1391K(20)
|
Full Article (PDF)-6724K(40)
|
Full Article (XML)-189K(23)
|
Times Cited (0)
|
Total Visits (1951)
|
Open
|
| 4 |
Yuxin Duan, Hua Zhang, Tao Tan, Wentao Ye, Kunli Yin, Yanxi Yu, Meiqing Kang, Jian Yang, Rui Liao. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy. BioScience Trends 2023; 17(6): 427 doi: 10.5582/bst.2023.01275
|
| 5 |
Hiroaki Takaya, Tadashi Namisaki, Soichi Takeda, Kosuke Kaji, Hiroyuki Ogawa, Koji Ishida, Yuki Tsuji, Hirotetsu Takagi, Takahiro Ozutsumi, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Norihisa Nishimura, Yasuhiko Sawada, Naotaka Shimozato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. Journal of Clinical Medicine 2021; 10(21): 4838 doi: 10.3390/jcm10214838
|
| 6 |
Qi-Feng Chen, Ning Lyu, Xun Wang, Xiong-Ying Jiang, Yue Hu, Song Chen, Sui-Xing Zhong, Zi-Lin Huang, Minshan Chen, Ming Zhao. Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000683
|
| 7 |
Kei Moriya, Tadashi Namisaki, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Naotaka Shimozato, Yasuhiko Sawada, Akitoshi Douhara, Shinya Sato, Masanori Furukawa, Koh Kitagawa, Takemi Akahane, Hitoshi Yoshiji. Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy. Journal of Clinical Medicine 2021; 10(4): 629 doi: 10.3390/jcm10040629
|
| 8 |
Yang Zhao, Fang Huang, Siye Liu, Lian Jian, Xibin Xia, Huashan Lin, Jun Liu. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score. Journal of Cancer Research and Clinical Oncology 2023; 149(8): 5181 doi: 10.1007/s00432-022-04467-3
|
| 9 |
Shijing Tang, Hao Chen.
Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(3): 51 doi: 10.1615/JEnvironPatholToxicolOncol.2024050167
|
| 10 |
Chanukya K. Colonne, Emmanuel J. Favaloro, Leonardo Pasalic. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer. Healthcare 2022; 10(3): 557 doi: 10.3390/healthcare10030557
|
| 11 |
Alexander H. Cotter, Su-Jau T. Yang, Hedyeh Shafi, Timothy M. Cotter, Darryl Erik Palmer-Toy. Elevated von Willebrand Factor Antigen Is an Early Predictor of Mortality and Prolonged Length of Stay for Coronavirus Disease 2019 (COVID-19) Inpatients. Archives of Pathology & Laboratory Medicine 2022; 146(1): 34 doi: 10.5858/arpa.2021-0255-SA
|